CPP-ACP (Casein Phosphopeptides)

CPP-ACP is one of the most extensively studied bioactive remineralizing agents in modern dentistry. What sets it apart is not simply delivering calcium and phosphate to the oral cavity, but holding them in a bioavailable form directly on the tooth surface where they are needed most.

What It Is

CPP-ACP stands for Casein Phosphopeptide–Amorphous Calcium Phosphate. The complex was developed at the University of Melbourne by Professor Eric Reynolds' team in the 1990s and commercialized under the Recaldent™ brand, used in MI Paste products (GC Corporation).

Casein is the primary protein in cow's milk (~80% of total milk protein). Enzymatic hydrolysis of casein yields peptides bearing phosphoserine clusters — sequences of several serine residues with covalently attached phosphate groups. These clusters, known as CPP, have a high affinity for Ca²⁺ and PO₄³⁻ ions. CPP captures these ions, preventing their premature crystallization into insoluble hydroxyapatite before reaching the tooth surface. The result is a stable CPP-ACP nanocomplex: a peptide "shell" that keeps amorphous calcium phosphate in a soluble, bioavailable state.

How It Works

Step 1 — Adsorption. After application, CPP-ACP binds to hydroxyapatite on the enamel surface and to proteins in the pellicle (the thin protein film that permanently coats teeth). CPP-ACP is also retained within the dental plaque biofilm.

Step 2 — Supersaturation at the enamel surface. The anchored complex slowly releases Ca²⁺ and PO₄³⁻ into the microenvironment immediately adjacent to enamel, creating local supersaturation with respect to calcium phosphate — the thermodynamic driving force for remineralization.

Step 3 — Ion diffusion into enamel pores. Calcium and phosphate ions diffuse through the micropores of demineralized enamel to zones of mineral loss, where they deposit new hydroxyapatite crystals or replenish partially dissolved existing crystals.

Step 4 — pH-responsive release. When cariogenic bacteria produce lactic acid, the acid attacks the CPP-ACP complex, releasing additional Ca²⁺ and PO₄³⁻ precisely in the acidic conditions — at the moment of greatest demineralization risk. This pH-dependent release is an intelligent feature: remineralization intensifies exactly where and when the threat is highest.

CPP-ACPF (with fluoride). Adding fluoride to CPP-ACP forms amorphous calcium fluoride phosphate (ACPF). During remineralization, fluoride is incorporated into the hydroxyapatite crystal lattice, forming fluorapatite — far more acid-resistant than standard hydroxyapatite. This explains the synergistic effect of combining CPP-ACP with fluoride.

Clinical Evidence

A 2025 systematic review (Madhivanan et al., PMID: 40863292) analyzing 14 randomized clinical trials confirmed that CPP-ACP significantly reduces the area and severity of white spot lesions (WSLs — early carious enamel) compared with placebo. The best outcomes were observed when CPP-ACP was combined with fluoride.

An earlier systematic review (Beerens et al., 2010, PMID: 24705069) documented a long-term in vivo remineralizing effect: with regular use over several weeks, CPP-ACP restores subsurface enamel mineral loss better than placebo, though results are generally below fluoride varnish.

A randomized trial by Sitthisettapong et al. (2015, PMID: 25895964) in children with early primary tooth caries found that 10% CPP-ACP paste used daily for 12 months significantly reduced caries progression versus placebo. Fluoride varnish was still more effective in that comparison.

Kumar et al. (2021, PMID: 34392591) found both CPP-ACP and fluoride delivered significant remineralization versus placebo; fluoride led on deeper lesions while CPP-ACP performed comparably on superficial demineralization.

When CPP-ACP works best:

• Reduced salivary flow (dry mouth, xerostomia) — CPP-ACP compensates when saliva's natural buffering is impaired
• Orthodontic patients — demineralization zones around brackets respond well
• Combined with fluoride — the CPP-ACPF formulation reliably outperforms either agent alone

Limitations:

| Condition | Reality | |---|---| | Low concentrations (chewing gum, <1%) | Minimal effect — insufficient dose | | Advanced caries | CPP-ACP does not treat caries — only remineralizes early lesions | | vs. 1450 ppm fluoride toothpaste | Fluoride remains the gold standard; CPP-ACP is a strong alternative for fluoride-averse patients | | Without daily use | Rapidly cleared by saliva; requires a consistent daily regimen |

Safety

CPP-ACP derives from casein in cow's milk and is classified as a food-grade protein product. Safety is well established.

Milk protein allergy. The only significant contraindication is allergy to cow's milk proteins (casein allergy). Products containing CPP-ACP may trigger an allergic reaction in sensitized individuals. This must be declared on packaging.

Lactose intolerance is not relevant. Lactose intolerance involves the enzyme lactase and is unrelated to casein. Lactose-intolerant individuals can use CPP-ACP products safely.

Regulatory status. Recaldent™ holds GRAS (Generally Recognized As Safe) status in the US for food applications. MI Paste products are sold over-the-counter in most markets. No systemic toxicity has been documented from topical oral use.

---

Sources:

• Madhivanan N et al. (2025). The Role of CPP-ACP in White Spot Lesion Remineralization — A Systematic Review. Dentistry Journal. PMID: 40863292
• Manton DJ et al. (2008). Remineralization of enamel subsurface lesions in situ. Int J Paediatr Dent. PMID: 16433964
• Sitthisettapong T et al. (2015). Efficacy of fluoride varnish and CPP-ACP for remineralization of primary teeth. Pediatr Dent. PMID: 25895964
• Beerens MW et al. (2010). Long-term remineralizing effect of CPP-ACP on early caries lesions in vivo. Caries Res. PMID: 24705069
• Kumar VL et al. (2021). Effectiveness of CPP-ACP and fluoride products in tooth remineralization. J Clin Diagn Res. PMID: 34392591